Ocular Therapeutix Inc earnings missed by $0.09, revenue fell short of estimates

Ocular Therapeutix Inc (NASDAQ: OCUL) reported first quarter EPS of $-0.38, $0.09 worse than the analyst estimate of $-0.29. Revenue for the quarter came in at $10.7M versus the consensus estimate of $17.07M.

 https://www.investing.com/news/earnings/ocular-therapeutix-inc-earnings-missed-by-009-revenue-fell-short-of-estimates-4021683